Arrowhead Pharmaceuticals Seeks Approval to Conduct Two Gene Therapy Clinical Trials – Los Angeles Business Journal
Los Angeles Business Journal |
Arrowhead Pharmaceuticals Seeks Approval to Conduct Two Gene Therapy Clinical Trials
Los Angeles Business Journal Arrowhead Pharmaceuticals Inc., which develops drugs to treat stubborn diseases by silencing the genes that cause them, reported it has filed for federal clearance to conduct to clinical studies of drugs aimed to treat liver disease and hepatitis B … |
